New gum surgery technique could save teeth from advanced gum disease

NCT ID NCT07671963

Recruiting now Disease control Sponsor: University of Belgrade Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This study tests two different bone graft materials (GTO® and GenOs®) used with a new, less invasive surgical method called NIPSA to repair bone damage from advanced gum disease. Researchers will compare how well each material helps reattach gums and fill in bone defects over 6 months. The trial is recruiting 30 adults with stage 3 periodontitis who have already had basic gum treatment.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: bone graft materials (GTO® and GenOs®)
What this could lead to: If successful, this could improve how dentists repair bone and gum damage caused by advanced gum disease, potentially saving more teeth.
What could go wrong: This is a small early study with only 30 people, so results may not apply to everyone. The surgery itself carries risks like infection or graft failure.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BONE SUBSTITUTES are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

periodontitis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BONE SUBSTITUTES MINIMALLY INVASIVE SURGICAL PROCEDURES PERIODONTITIS (STAGE 3)

Contacts and locations

Locations

Department of Periodontology and Research Implant Center, School of Dental Medicine, University of Belgrade
RECRUITING

Belgrade, Serbia
Department of Periodontology, School of Dental Medicine, University of Cagliari Cittadella Universitaria di Monserrato Monserrato (CA), Italy
RECRUITING

Cagliari, Italy, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.